Leadership Team

Marcia recently retired as a VP of Statistics at Pfizer with responsibility for clinical development in the CVMET therapeutic area and globally sponsored Pfizer’s China Research & Development Center (CRDC) Statistics organization.  While at Pfizer Marcia led the global biometrics organization for Pfizer’s marketed medicines clinical research programs and established regional biometrics centers for Latin America, Europe, Asia and China. Marcia has extensive experience in the analysis and interpretation of clinical trial data across numerous therapeutic areas, particularly in Cardiovascular and Anti-infectives.  She has served as the statistical leader for regulatory submissions with the responsibility of ensuring biometrics business support of the global pharmaceutical product portfolio. In addition to her role leading Statistics groups, Marcia was a member of Pfizer’s team for the clinical trial disclosure policy, and played a key leadership role in defining Pfizer policy on the issue.  She was a member of Pfizer’s internal steering committee for their Bioethics Advisory Panel and a member of Pfizer’s Clinical Trials Policy Group. She is a member of the Stevens Institute Business Intelligence & Analytics Program Advisory Board, which she joined in 2012. She is a member of the ASA Committee on Professional Ethics. Marcia holds BS degrees in Mathematics and Life Sciences from MIT, an MS in Biostatistics form UNC,  and an ScD in Biostatistics from Harvard University. She received a Masters in Bioethics form U Penn in 2012.